Our outstanding team of physicians is expert in diagnosing and treating Parkinson's disease and other movement disorders.
These include atypical parkinsonism (including multiple systems atrophy, corticobasal ganglionic degeneration, and progressive supranuclear palsy), dystonia, essential tremor, Huntington's disease, and other disorders with chorea, tic disorders, and amyotropic lateral sclerosis (ALS, also known as Lou Gehrig's disease). Our expertise spans all ages and includes specialization in pediatric movement disorders.
Our movement disorders program offers unparalleled multidisciplinary diagnosis and care at two locations:
At The Mount Sinai Hospital, a leading expert on musician's dystonia, leads the Robert and John M. Bendheim Parkinson and Movement Disorders Center.
At Mount Sinai Beth Israel, Susan Bressman, MD, leads the Movement Disorders Center, which is designated as both a National Parkinson's Foundation and Bachmann Strauss Dystonia and Parkinson's Center of Excellence. Dr. Bressman is internationally recognized for her clinical expertise and research characterizing the genetics of Parkinson's disease and dystonia.
The Beth Israel ALS Center, co-sponsored by the Greater New York Chapter of the ALS Association, offers state-of-the-art treatment for ALS. Barbara Coffey, MD, and her colleagues provide world-class treatment to those with Tourette's syndrome or other tic disorders.
Our team includes 12 fellowship-trained neurologists, two neuropsychologists, a neuropsychiatrist, neurosurgeon, two nurse practitioners, and two genetic counselors, all dedicated to providing you the most advanced and compassionate care. Our comprehensive program includes diagnostic evaluation and treatment, as well as supportive services, such as mental health care, social work support, information about and evaluation for clinical research studies, and physical and speech therapy. We also host patient and caregiver programs that include support groups, educational symposia, and exercise classes.
Our centers are recognized leaders in movement disorders research and participate in groundbreaking work in the genetics of dystonia and Parkinson's disease, translational studies that join the clinical and laboratory scientists, and cutting-edge clinical trials. These include:
- Studies of the relationship between brain changes and genetic factors in spasmodic dysphonia, a form of focal dystonia.
- Experimental therapeutics for Parkinson's disease, dystonia, essential tremor, and other movement disorders.
- Exploration of the genetic mechanisms underlying dystonia, Parkinson's disease, and spasmodic dysphonia.
- Research into the behavioral aspects of Parkinson's disease, such as emotional processing deficits and impulse control disorders as well as the effects of deep brain stimulation on Parkinson's disease motor features and gait disorders.